Vaccines for COVID-19: Canada’s vaccine supply
On this page
- Making vaccines available to everyone
- Vaccine distribution
- Forecasted allocation of COVID-19 vaccines
Making vaccines available to everyone
COVID-19 vaccines are available to every eligible person in Canada. There are currently enough mRNA vaccine doses in Canada to meet the needs of the eligible population in accordance with NACI recommendations.
Vaccine supply continues to be managed strategically to best support both Canada's evolving domestic needs and global vaccination efforts.
Canada's vaccine supply includes a central inventory allocated to the provinces and territories and held at their request. It also includes supply to provide provinces and territories with continued access to vaccines for newly eligible populations and for additional doses that may be needed over time.
The vaccine distribution table (updated every Thursday) below describes the quantities of COVID-19 vaccines that have been delivered to provinces and territories.
Vaccine distribution
As of March 31, 2022 there are 11,614,504 COVID-19 vaccine doses in the central vaccine inventory.
AstraZeneca COVID-19 vaccine include vaccine doses coming from the Serum Institute of India, United States and the COVAX initiative.
Vaccine distribution | Pfizer/BioNTech Comirnaty | Pfizer/BioNTech Comirnaty (ages 5 - 11) | Moderna SpikeVaxFootnote 1 | AstraZeneca | Janssen | Total |
---|---|---|---|---|---|---|
Total distributed in Canada | 59,326,050 | 4,875,530 | 28,899,470 | 3,061,910 | 44,400 | 96,207,360 |
Newfoundland and Labrador | 818,610 | 68,000 | 555,224 | 41,300 | 250 | 1,483,384 |
Prince Edward Island | 273,495 | 24,000 | 116,380 | 10,200 | 500 | 424,575 |
Nova Scotia | 1,577,592 | 116,200 | 701,500 | 60,960 | 2,000 | 2,458,252 |
New Brunswick | 1,328,295 | 112,000 | 648,950 | 61,500 | 700 | 2,151,445 |
Quebec | 13,916,433 | 1,304,000 | 6,720,276 | 742,110 | 100 | 22,682,919 |
Ontario | 22,264,641 | 1,614,000 | 11,320,350 | 1,168,300 | 10,000 | 36,377,291 |
Manitoba | 2,354,340 | 252,000 | 1,034,308 | 92,960 | 3,250 | 3,736,858 |
Saskatchewan | 2,037,915 | 185,000 | 662,220 | 108,600 | 5,000 | 2,998,735 |
Alberta | 7,167,225 | 788,000 | 2,721,254 | 318,700 | 10,000 | 11,005,179 |
British Columbia | 7,532,910 | 381,800 | 3,920,040 | 456,800 | 12,400 | 12,303,950 |
Yukon | 8,190 | 5,000 | 87,470 | 20 | 200 | 100,880 |
Northwest Territories | 14,040 | 8,000 | 91,470 | 0 | 0 | 113,510 |
Nunavut | 17,550 | 14,400 | 71,680 | 0 | 0 | 103,630 |
Federal allocationFootnote 2 | 14,814 | 3,130 | 248,348 | 460 | 0 | 266,752 |
|
Forecasted allocation of COVID-19 vaccines
Forecasted allocation of COVID-19 vaccines to provinces and territories
Vaccine allocation tables describe the forecasted number of vaccine doses available to provinces and territories, based on arriving supply. The table describes cumulative allocations as of March 31, 2022.
Vaccine allocation | Novavax Nuvaxovid |
---|---|
Total allocated in Canada | 1,000,000 |
Newfoundland and Labrador | 13,500 |
Prince Edward Island | 4,300 |
Nova Scotia | 25,800 |
New Brunswick | 20,500 |
Quebec | 221,100 |
Ontario | 383,400 |
Manitoba | 34,900 |
Saskatchewan | 29,700 |
Alberta | 112,800 |
British Columbia | 135,800 |
Yukon | 1,100 |
Northwest Territories | 1,100 |
Nunavut | 1,000 |
Federal allocationFootnote 1 | 15,000 |
|
Related links
- Date modified: